367 related articles for article (PubMed ID: 25170198)
1. Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.
Grassi A; Ballardini G
World J Gastroenterol; 2014 Aug; 20(32):11095-115. PubMed ID: 25170198
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?
Dall'Agata M; Gramenzi A; Biselli M; Bernardi M
World J Gastroenterol; 2014 Jul; 20(28):9253-60. PubMed ID: 25071318
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatitis C after liver transplant.
deLemos AS; Schmeltzer PA; Russo MW
World J Gastroenterol; 2014 Aug; 20(31):10668-81. PubMed ID: 25152571
[TBL] [Abstract][Full Text] [Related]
4. Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant.
Papadopoulos-Köhn A; Achterfeld A; Paul A; Canbay A; Timm J; Jochum C; Gerken G; Herzer K
Transplantation; 2015 Apr; 99(4):841-7. PubMed ID: 25208324
[TBL] [Abstract][Full Text] [Related]
5. Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.
Dumortier J; Boillot O; Scoazec JY
World J Gastroenterol; 2014 Aug; 20(32):11069-79. PubMed ID: 25170196
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression, liver injury and post-transplant HCV recurrence.
Ciesek S; Wedemeyer H
J Viral Hepat; 2012 Jan; 19(1):1-8. PubMed ID: 22187942
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis viruses and liver transplantation.
Samuel D; Feray C; Bismuth H
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
[TBL] [Abstract][Full Text] [Related]
8. HCV in liver transplantation.
Germani G; Tsochatzis E; Papastergiou V; Burroughs AK
Semin Immunopathol; 2013 Jan; 35(1):101-10. PubMed ID: 22829333
[TBL] [Abstract][Full Text] [Related]
9. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis.
Freeman RB; Tran S; Lee YM; Rohrer RJ; Kaplan MM
Transplantation; 1996 Feb; 61(4):542-6. PubMed ID: 8610378
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation for viral hepatitis in 2015.
Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
[TBL] [Abstract][Full Text] [Related]
11. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C.
Burra P
Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
[TBL] [Abstract][Full Text] [Related]
13. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
[TBL] [Abstract][Full Text] [Related]
15. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
[TBL] [Abstract][Full Text] [Related]
16. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
Lanini S; Nanni Costa A; Grossi PA; Procaccio F; Ricci A; Capobianchi MR; Terrault NA; Ippolito G
Liver Int; 2016 Mar; 36(3):410-7. PubMed ID: 26264452
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
18. Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.
Ghanekar A; Kashfi A; Cattral M; Selzner N; McGilvray I; Selzner M; Renner E; Lilly L; Levy G; Grant D; Greig P
Transplant Proc; 2012 Jun; 44(5):1351-6. PubMed ID: 22664014
[TBL] [Abstract][Full Text] [Related]
19. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
Caston JJ; Castells L; Varo E; Gomez MA; de la Mata M; Campos-Varela I; Lumbreras C; Gonzalez-Dieguez L; Fabregat J; Herrero I; Salcedo M; Sanchez-Antolín G; Torre-Cisneros J
Transplantation; 2016 Mar; 100(3):593-9. PubMed ID: 26371595
[TBL] [Abstract][Full Text] [Related]
20. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
